Skip to content

Insider · CIK 0002010225

Christopher P. Acevedo

cfoofficer

Files at OSTX (OS Therapies Inc). First filing -, latest -.

Christopher P. Acevedo files SEC Form 4 as CFO at OSTX (OS Therapies Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Christopher P. Acevedo has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 22, 2026OSTX
OS Therapies Inc
AGrant or award
Stock options (right to buy)derivative
+100,000$0.00$0100,000Feb 13, 2026
Oct 21, 2025OSTX
OS Therapies Inc
AGrant or award
Stock options (right to buy)derivative
+200,000$0.00$0200,000Dec 19, 2025

Questions about Christopher P. Acevedo

Answered from the filings on this page, as of the latest one.

Is Christopher P. Acevedo buying or selling?

Christopher P. Acevedo has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Christopher P. Acevedo's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher P. Acevedo has 0.

Where does Christopher P. Acevedo file Form 4?

Christopher P. Acevedo has filed Form 4 at OSTX (OS Therapies Inc) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher P. Acevedo: insider trades and track record | InsiderTell